# DAPAGLIFLOZIN

NDC: 46708-392
Generic name: DAPAGLIFLOZIN
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20260406

FDA application: ANDA211560

## Active ingredients

- DAPAGLIFLOZIN: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-392"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-392
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d44f7eed-dd51-40d1-8408-8fb331e1f1f6